Roche does $400M upfront, $15B deal with China's Hansoh
PartnershipPositive
AI Analysis
Summary
Roche signed a major collaboration with China's Hansoh Pharmaceutical featuring $400 million upfront and up to $15 billion in potential milestone payments. It is described as one of the largest cross-border collaborations of the year.
Outcome Details
Roche to pay $400 million upfront with potential total deal value of up to $15 billion in milestone payments (biobucks), described as one of the largest cross-border collaborations of the year.
Importance:8/10
Sentiment:
0.70
partnershiplicensingchinacross-borderupfront-paymentbiobucksdrug-discovery
Read the original article
Published by Endpoints News on October 19, 2026 11:08 AM